share_log

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON JOHN

SEC announcement ·  Apr 1 17:48
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more